EGR2 Antikörper (AA 200-300)
-
- Target Alle EGR2 Antikörper anzeigen
- EGR2 (Early Growth Response 2 (EGR2))
-
Bindungsspezifität
- AA 200-300
-
Reaktivität
- Human, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EGR2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Reacts with human EGR-2
- Kreuzreaktivität
- Maus, Huhn, Schwein
- Kreuzreaktivität (Details)
- Cross reacts with porcine protein. May cross react with proteins from mouse, rat, chicken and Xenopus (86 % sequence homology).
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic peptide made to a portion of human EGR2 protein sequence within residues 200-300
- Top Product
- Discover our top product EGR2 Primärantikörper
-
anti-Early Growth Response 2 (EGR2) (AA 147-403) antibody
EGR2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Early Growth Response 2 (EGR2) (C-Term) antibodyEGR2 Reaktivität: Human, Maus, Ratte, Hund, Pferd, Schwein, Rind (Kuh), Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Early Growth Response 2 (EGR2) (Internal Region) antibodyVerified EGR2 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Early Growth Response 2 (EGR2) (AA 397-446) antibodyEGR2 Reaktivität: Human, Maus, Pferd, Rind (Kuh), Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Early Growth Response 2 (EGR2) (AA 217-293) antibodyEGR2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1G5 unconjugated
anti-Early Growth Response 2 (EGR2) (AA 156-476) antibodyEGR2 Reaktivität: Human WB, IHC, IF, IHC (p) Wirt: Maus Monoclonal 1B12 unconjugated
anti-Early Growth Response 2 (EGR2) (AA 42-245) antibodyEGR2 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Early Growth Response 2 (EGR2) antibodyEGR2 Reaktivität: Human WB, IP Wirt: Kaninchen Monoclonal unconjugated
anti-Early Growth Response 2 (EGR2) antibodyEGR2 Reaktivität: Human WB, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Early Growth Response 2 (EGR2) (AA 1-476) antibodyEGR2 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- WB : 2 μg/mL - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.9 mg/mL
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.1 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 6 months
-
- Target
- EGR2 (Early Growth Response 2 (EGR2))
- Andere Bezeichnung
- E3 SUMO-Protein Ligase EGR2 (EGR2 Produkte)
- Synonyme
- AT591 antikoerper, CMT1D antikoerper, CMT4E antikoerper, KROX20 antikoerper, Egr-2 antikoerper, Krox-20 antikoerper, Krox20 antikoerper, NGF1-B antikoerper, Zfp-25 antikoerper, Zfp-6 antikoerper, KRX-20 antikoerper, cb427 antikoerper, egr2 antikoerper, id:ibd5073 antikoerper, krox20 antikoerper, krx20 antikoerper, wu:fb71h10 antikoerper, zgc:92210 antikoerper, frb35 antikoerper, early growth response 2 antikoerper, early growth response 2b antikoerper, early growth response 2a antikoerper, EGR2 antikoerper, Egr2 antikoerper, egr2b antikoerper, egr2a antikoerper
-
